Evaluation of impact of clinical variables on enoxaparin dosing and anti-Xa factor concentration.

BACKGROUND: Enoxaparin, a low molecular weight heparin, is widely used for venous thromboembolism treatment and prevention. While routine anti-factor Xa (anti-Xa) monitoring is not generally required, it may be valuable in high-risk populations such…

Preview only. Read the full abstract at the source